Colistimethate injection is an antibiotic medication used for the treatment of severe or life-threatening infections caused by certain types of bacteria. It is commonly used to treat infections caused by multidrug-resistant gram-negative bacteria, such as Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae. These types of infections may occur in people who have weakened immune systems, burn wounds, or cystic fibrosis. Colistimethate injection works by interfering with the growth and reproduction of the bacteria, helping to clear the infection and prevent it from spreading.
Colistimethate Sodium Injection 150 mg Per Vial by Fresenius Kabi is a medication used in the treatment of serious bacterial infections, including respiratory tract infections and infections caused by certain types of bacteria that are resistant to other antibiotics. It is a sterile powder that is reconstituted with water for injection and then administered intravenously. It is a type of antibiotic called a polymyxin and works by disrupting the cell walls of bacteria, leading to their death. Fresenius Kabi is the pharmaceutical company that manufactures and sells this medication.
Colistimethate Sodium Injection 150 mg Per Vial by Fresenius KabiÂ
Benefits of Colistimethate Sodium Injection 150 mg per vial include its ability to treat serious bacterial infections, particularly those caused by multi-drug resistant organisms. It is also considered to have a relatively low toxicity profile and can be administered via intravenous or intramuscular injection, providing flexibility in treatment options. Additionally, its long-acting formulation means that it only needs to be administered once or twice daily, reducing the burden on patients and healthcare providers. Overall, Colistimethate Sodium Injection 150 mg per vial may provide a viable treatment option for infections that are resistant to other antibiotics.Â
Skip to content
